Island Pharmaceuticals Limited (ILA.AX)
AUD 0.18
(2.94%)
AUD 0.18
(2.94%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.25 Million AUD | 11211.12% |
| 2023 | 11.06 Thousand AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q4 | -344.62 Thousand AUD | 0.0% |
| 2024 Q2 | -165.87 Thousand AUD | 0.0% |
| 2024 Q3 | -344.62 Thousand AUD | -107.77% |
| 2024 Q1 | -165.87 Thousand AUD | -3097.85% |
| 2023 Q2 | -335.11 Thousand AUD | 0.0% |
| 2023 Q1 | -335.11 Thousand AUD | 0.0% |
| 2023 FY | 11.06 Thousand AUD | 0.0% |
| 2023 Q4 | 5533.00 AUD | 0.0% |
| 2023 Q3 | 5533.00 AUD | 101.65% |
| 2022 Q3 | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 97.543% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 267.12% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -12070.119% |
| Biome Australia Limited | 7.66 Million AUD | 83.681% |
| Patrys Limited | 1.39 Million AUD | 10.227% |
| Orthocell Limited | 3.68 Million AUD | 66.067% |
| Imugene Limited | -5.83 Million AUD | 121.432% |
| Noxopharm Limited | -534.81 Thousand AUD | 334.022% |
| PYC Therapeutics Limited | 22.05 Million AUD | 94.326% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 83.209% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 66.286% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 211.43% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 45.951% |
| CSL Limited | 15.28 Billion AUD | 99.992% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 4917.641% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 515.186% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 98.397% |
| Starpharma Holdings Limited | 7.65 Million AUD | 83.654% |
| Nanollose Limited | -348.95 Thousand AUD | 458.667% |
| Memphasys Limited | 1606.00 AUD | -77831.196% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -3.243% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 1470.283% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 68.795% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 119.104% |
| Race Oncology Limited | 1.38 Million AUD | 9.953% |
| Nyrada Inc. | -5164.07 AUD | 24336.213% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.594% |
| Dimerix Limited | 583.47 Thousand AUD | -114.503% |
| PharmAust Limited | -1641.00 AUD | 76369.043% |
| Immutep Limited | 1.44 Million AUD | 13.32% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 89.123% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 67.107% |
| BTC Health Limited | 16.36 Thousand AUD | -7550.214% |
| Acrux Limited | -1.28 Million AUD | 197.475% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.39% |
| Biotron Limited | -40.49 Thousand AUD | 3190.461% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -731.551% |
| AdAlta Limited | 1.5 Million AUD | 17.0% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 105.874% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -171.847% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -2103.012% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 441.244% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 2957.803% |
| Actinogen Medical Limited | 9.93 Million AUD | 87.398% |
| Immuron Limited | 3.33 Million AUD | 62.492% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 51.824% |